Kyverna Therapeutics, Inc. KYTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Kyverna Therapeutics, Inc. (KYTX) reported operating lease right-of-use assets in other assets of $8.19M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 42.1% year-over-year, from $5.76M to $8.19M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -25.9% compound annual growth rate (CAGR), from $6.49M to $3.57M.